OR WAIT null SECS
June 10, 2024
The new meeting program will create a dialogue around AI and be administered through CDER’s Emerging Drug Safety Technology Program.
May 18, 2024
Bari Kowal, senior vice-president, head Development Operations & Portfolio Management, Regeneron, discussed the utility of AI and how it can benefit R&D work.
May 06, 2024
Digital transformation is allowing for better handling, analysis, and protection of vast data collection.
March 04, 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
February 29, 2024
This discussion explores how the management and analysis of vast data generated by advanced analytical technologies are revolutionizing the drug discovery and development process within the biopharma industry.
December 08, 2023
MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.
December 06, 2023
Best practice methods for the tech transfer of CGTs can increase process and analytics robustness while remaining scalable.
November 29, 2023
Under this multi-year collaboration, Genentech and NVIDIA will use AI to optimize and accelerate each company’s platforms to discover and develop innovative therapeutics.
December 07, 2022
Advancing digital transformation can significantly reduce R&D costs and shorten drug discovery timelines.
July 08, 2022
VeriSIM Life and Mayo Clinic are collaborating to develop new promising drug candidates.